Free shipping on all orders over $ 500
  Catalog
Abmole Inhibitor Catalog 2017

PPAR Peroxisome Proliferator Activated Receptor

Inhibitors

Cat.No.  Name Information
M9195 Saroglitazar Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity, with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.
M5940 Rosiglitazone HCl Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
M5927 Retinoic acid All-trans retinoic acid (ATRA; Vitamin A acid) has been widely investigated for treatments of many cancers including prostate cancer.
M5878 Pioglitazone HCl Pioglitazone HCl is a selective peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist, used to treat diabetes.
M5641 Fenofibric acid Fenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides.
M5530 Clofibrate Clofibrate (Atromid-S), a fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia.
M5171 Troglitazone (CS-045) Troglitazone is a potent agonist for the peroxisome proliferator-activated receptor-(PPAR) that is a ligand activated transcription factor regulating cell differentiation and growth.
M3658 GW501516 GW501516 is a potent and highly selective PPARβ/δ agonist, with EC50 of 1 nM, with 1000-fold selectivity over hPPARα and hPPARγ.
M3635 FH535 FH535 is a compound that suppresses both Wnt/beta-catenin and peroxisome proliferator-activated receptor (PPAR) signaling.
M3283 Pioglitazone Pioglitazone (Actos) is a selective peroxisome proliferator-activated receptor gamma stimulator.
M3044 T0070907 T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM, with a >800-fold selectivity over PPARα and PPARδ.
M2748 GW9662 GW9662 is a selective PPAR antagonist for PPARγ with IC50 of 3.3 nM, with at least 100 to 1000-fold functional selectivity in cells with PPARγ versus PPARα and PPARδ.
M2747 GW7647 GW7647 is a potent and highly selective PPARα agonist with EC50 of 6 nM.
M2742 GW0742 GW0742 is a potent and highly selective PPARβ/δ agonist, with IC50 of 1 nM, with 1000-fold selectivity over hPPARα and hPPARγ.
M2732 GSK0660 GSK0660 is a selective PPARδ antagonist with IC50 of 155 nM.
M2455 Bezafibrate Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.
M2335 ZLN005 ZLN005 is a novel and potent small molecule PGC-1α transcriptional activator.
M2200 Ciprofibrate Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist.
M2038 Rosiglitazone maleate Rosiglitazone maleate (Avandia) is a potent and selective PPARγ ligand that binds to the PPARγ ligand-binding domain with a Kd value of 43 nM.
M2033 GSK 3787 GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6).
M1894 Rosiglitazone Rosiglitazone is a selective ligand of peroxisome proliferator-activated receptor gamma (PPARgamma).
M1880 WY 14643 WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist.
M1602 SR1664 SR1664 is an antidiabetic agent which binds to PPARγ and potently inhibits Cdk5-mediated PPARγ phosphorylation with IC50 of 80 nM and Ki of 28.67 nM.


Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.